TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30927041

Group type: EXPERIMENTAL
Intervention: Active tDCS (1 mA for 30 min over auditory regions of temporal lobe)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study: 29388929

Group type: EXPERIMENTAL
Intervention: Selective electrical stimulation using the 'LymphaVision' apparatus
Number of subjects: 42

Group type: COMPARATOR
Intervention: Vermel electrophoresis with 1% sodium bromide solution
Number of subjects: 42
Study: 25524559

Group type: EXPERIMENTAL
Intervention: Novel strategy (group B) including access to a website, patient-targeted brochures, clinician-targeted education, and pocket referral cards.
Number of subjects: 820

Group type: COMPARATOR
Intervention: Usual care (group A)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Novel strategy (group B)
Number of subjects: 820
Study: 25362228

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) dalteparin
Number of subjects: 2344

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 2344
Study: 22844152

Group type: EXPERIMENTAL
Intervention: Taped numbers (TN) intervention
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Taped numbers (TN) intervention supplemented with performance feedback, reinforcement, and overcorrection
Number of subjects: 4
Study: 19126117

Group type: EXPERIMENTAL
Intervention: Adrenomedullin (0.08 microg kg(‐1) min(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%)
Number of subjects: 12
Study: 17260532

Group type: EXPERIMENTAL
Intervention: High sucrose diet (HD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High fat diet (HFD)
Number of subjects: 20
Study: 14749693

Group type: EXPERIMENTAL
Intervention: Lanreotide 100 microg/h infusion for 8 hours
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lanreotide 800 microg bolus injection
Number of subjects: 12
Study: 11679509

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (100 mg on days 5-9)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fertile women (control group)
Number of subjects: 40
Study: 9129858

Group type: EXPERIMENTAL
Intervention: Hormone therapy (specific dosage and duration not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized recommendation to use or not use hormone therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion groups and questionnaires
Number of subjects: 0
Study: 7955439

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3591257

Group type: EXPERIMENTAL
Intervention: Oral clonidine (225-375 micrograms) + diazepam (5-15 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cimetidine (300 mg the night before and 300 mg in the morning) + diazepam
Number of subjects: 63
Study: 29478724

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) for identification of ETT placement
Number of subjects: 32
Study: 27658881

Group type: EXPERIMENTAL
Intervention: CBT-AD
Number of subjects: 240

Group type: COMPARATOR
Intervention: ISP-AD
Number of subjects: 240

Group type: COMPARATOR
Intervention: ETAU
Number of subjects: 240
Study: 24336948

Group type: EXPERIMENTAL
Intervention: Pacemaker therapy in patients with negative tilt test (TT-), 26 patients
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Pacemaker therapy in patients with positive tilt test (TT+), 26 patients
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (untreated patients), 45 patients
Number of subjects: 136
Study: 22434182

Group type: EXPERIMENTAL
Intervention: β‐alanine (BA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: maltodextrin (MD)
Number of subjects: 36
Study: 19958342

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Pressure controlled ventilation
Number of subjects: 68
Study: 17353402

Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) solution
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trypan blue (TB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both ICG and TB
Number of subjects: 40
Study: 15475124

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isometric exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 11528550

Group type: EXPERIMENTAL
Intervention: Prednisone treatment with initial leukaemic blood blast count < 1000 blasts/microliter
Number of subjects: 660

Group type: COMPARATOR
Intervention: Prednisone treatment with initial leukaemic blood blast count >= 1000 blasts/microliter
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Patients with < 1000 blasts/microliter on day eight of treatment but increasing blast count
Number of subjects: 660
Study: 9989332

Group type: EXPERIMENTAL
Intervention: Home-based, self-contained nutrition education program (PCAT program)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Dietary counseling with a registered dietician
Number of subjects: 263

Group type: COMPARATOR
Intervention: At-risk control group
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Nutrition education interventions (general)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Parental dietary control
Number of subjects: 263
Study: 7607785

Group type: EXPERIMENTAL
Intervention: Mazindol (0.5 mg, three tablets per day for three months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (three tablets per day for three months)
Number of subjects: 36
Study: 3125352

Group type: EXPERIMENTAL
Intervention: Medium Chain Triglyceride/Long Chain Triglyceride (MCT/LCT) emulsion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional Long Chain Triglyceride (LCT)
Number of subjects: 10
Study: 29739354

Group type: EXPERIMENTAL
Intervention: Icodextrin solution (ICO)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Glucose-based solution (GLU)
Number of subjects: 43
Study: 26513335

Group type: EXPERIMENTAL
Intervention: On-road motorcycle rider coaching program (4h riding and facilitated discussion)
Number of subjects: 2399

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2399
Study: 24373856

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF) applied biannually for 24 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: No topical fluoride treatment (active caries)
Number of subjects: 12
Study: 23593205

Group type: EXPERIMENTAL
Intervention: Sodium thiosulfate (STS) 10 mmol twice a day for 7 days
Number of subjects: 10
Study: 20598745

Group type: EXPERIMENTAL
Intervention: Home-based educational intervention
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study: 19052406

Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% ointment applied twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tazarotene 0.05% gel applied once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tazarotene 0.1% gel applied once daily
Number of subjects: 20
Study: 16889629

Group type: EXPERIMENTAL
Intervention: Modified sonic scaler system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Scaling and root planing (S/RP) with hand instruments
Number of subjects: 20

Group type: COMPARATOR
Intervention: S/RP
Number of subjects: 20
Study: 14994963

Group type: EXPERIMENTAL
Intervention: Doxazosin gastrointestinal therapeutic system (doxazosin-GITS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamsulosin
Number of subjects: 0
Study: 11673585

Group type: EXPERIMENTAL
Intervention: 8.0 mg albuterol twice daily
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 16.0 mg albuterol twice daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 9779523

Group type: EXPERIMENTAL
Intervention: DigiTrace Home Sleep System (DHSS)
Number of subjects: 93
Study: 7880766

Group type: EXPERIMENTAL
Intervention: Systematic tracheostomy weaning procedure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Random tracheostomy weaning procedure
Number of subjects: 30
Study: 3278581

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Maximal accomplished workload at 6 weeks
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Previous AMI
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Left ventricular failure
Number of subjects: 301

Group type: COMPARATOR
Intervention: Exercise-induced ST-depression (≥ 1 mm) in placebo-treated patients
Number of subjects: 301
Study: 30877066

Group type: EXPERIMENTAL
Intervention: Lycium barbarum (LB) supplement
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 28667224

Group type: EXPERIMENTAL
Intervention: GAS method (gather-analyse-summarise)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: TeamTAG (teamwork techniques analysis grid)
Number of subjects: 35
Study: 25358449

Group type: EXPERIMENTAL
Intervention: Enhanced Dietary Counseling (EDC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard of Care Dietary Counseling (SDC)
Number of subjects: 47
Study: 24128861

Group type: EXPERIMENTAL
Intervention: Fludarabine plus cyclophosphamide (FC) chemotherapy
Number of subjects: 455

Group type: COMPARATOR
Intervention: Chlorambucil
Number of subjects: 455

Group type: COMPARATOR
Intervention: Fludarabine
Number of subjects: 455
Study: 22506139

Group type: EXPERIMENTAL
Intervention: Mirror therapy and NMES
Number of subjects: 60

Group type: COMPARATOR
Intervention: NMES only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mirror therapy only
Number of subjects: 60
Study: 19692530

Group type: EXPERIMENTAL
Intervention: Tart cherry juice (240 mL twice daily for 14 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (240 mL twice daily for 14 days)
Number of subjects: 12
Study: 16508640

Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide 750 mg/m², doxorubicin 50 mg/m², vincristine 1.4 mg/m², prednisolone 100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PMitCEBO (mitoxantrone 7 mg/m², cyclophosphamide 300 mg/m², etoposide 150 mg/m², vincristine 1.4 mg/m², bleomycin 10 mg/m², prednisolone 50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 0

Group type: COMPARATOR
Intervention: No G-CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHOP
Number of subjects: 0

Group type: COMPARATOR
Intervention: PMitCEBO
Number of subjects: 0
Study: 14631835

Group type: EXPERIMENTAL
Intervention: Spontaneous intracerebral hemorrhage (SIHP) group
Number of subjects: 500
Study: 11020593

Group type: EXPERIMENTAL
Intervention: STD counseling interventions (Project RESPECT)
Number of subjects: 3498

Group type: EXPERIMENTAL
Intervention: Baseline misconceptions (e.g., washing genitals after sex, urinating after sex, douching, use of oral contraceptives)
Number of subjects: 3498

Group type: EXPERIMENTAL
Intervention: Persistent misconceptions
Number of subjects: 3498
Study: 9068812

Group type: EXPERIMENTAL
Intervention: Killed Mycobacterium vaccae as immunotherapy
Number of subjects: 206

Group type: COMPARATOR
Intervention: Saline as placebo (control)
Number of subjects: 206
Study: 8436780

Group type: EXPERIMENTAL
Intervention: Elimination diets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonatopic control subjects
Number of subjects: 0
Study: 3096133

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (12.5 to 50 mg) applied to the arm
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (12.5 to 50 mg) applied to the chest
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (12.5 to 50 mg) applied to the thigh
Number of subjects: 9
Study: 30088145

Group type: EXPERIMENTAL
Intervention: SURE (Strength for U in Relationship Empowerment) intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 28768165

Group type: EXPERIMENTAL
Intervention: Elevated plasma mannose levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 26184986

Group type: EXPERIMENTAL
Intervention: Community-based self-management intervention (12 hours of group education sessions, integrated counseling, and behavioral coaching)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Community-based self-management intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 250
Study: 25236509

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1850

Group type: COMPARATOR
Intervention: PCI/DES
Number of subjects: 1850
Study: 21851019

Group type: EXPERIMENTAL
Intervention: Fast Track Surgery (FTS) program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional postoperative mode (Control)
Number of subjects: 44
Study: 19675365

Group type: EXPERIMENTAL
Intervention: Moderate alcohol dose
Number of subjects: 413

Group type: COMPARATOR
Intervention: Nonalcoholic beverage
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Low alcohol dose
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: High alcohol dose
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Established relationship
Number of subjects: 413
Study: 17343006

Group type: EXPERIMENTAL
Intervention: Fructus Bruceae oil emulsion (FBE) combined with chemotherapy (GP regimen)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Chemotherapy (GP regimen) only
Number of subjects: 115
Study: 15295219

Group type: COMPARATOR
Intervention: Palivizumab 5 mg/kg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Palivizumab 15 mg/kg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 11805893

Group type: EXPERIMENTAL
Intervention: Suction drains
Number of subjects: 100

Group type: COMPARATOR
Intervention: No suction drains
Number of subjects: 100
Study: 9568783

Group type: EXPERIMENTAL
Intervention: Dietary calcium intake (fifth quintile)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium supplements
Number of subjects: 0
Study: 8113835

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Intensive chemotherapy
Number of subjects: 78
Study: 3382595

Group type: EXPERIMENTAL
Intervention: Metoclopramide with oral controlled release morphine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral controlled release morphine alone
Number of subjects: 20
Study: 30900194

Group type: EXPERIMENTAL
Intervention: Animal Assisted Therapy (AAT) with dogs
Number of subjects: 53

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 53
Study: 30733800

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA, 20 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 8
Study: 28544071

Group type: EXPERIMENTAL
Intervention: Perineal hydrodissection (HD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 21
Study: 26594989

Group type: EXPERIMENTAL
Intervention: Computed inferior alveolar nerve block technique
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional inferior alveolar nerve block technique
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 29
Study: 22964343

Group type: EXPERIMENTAL
Intervention: Immediate Intervention Group (IIG) - Relaxation therapy days 3-6
Number of subjects: 18

Group type: COMPARATOR
Intervention: Delayed Intervention Group (DIG) - Relaxation therapy days 6-9
Number of subjects: 18
Study: 21361811

Group type: EXPERIMENTAL
Intervention: High call completion during the maintenance-enhancement phase
Number of subjects: 228
Study: 20205023

Group type: EXPERIMENTAL
Intervention: Index of Self‐Regulation of Emotion (ISE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Miller Behavioural Style Scale (MBSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mainz Coping Inventory (MCI)
Number of subjects: 0
Study: 17404163

Group type: EXPERIMENTAL
Intervention: Sibutramine (15 mg)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Felodipine 5 mg/ramipril 5 mg
Number of subjects: 171

Group type: COMPARATOR
Intervention: Verapamil 180 mg/trandolapril 2 mg
Number of subjects: 171

Group type: COMPARATOR
Intervention: Metoprolol succinate 95 mg/hydrochlorothiazide 12.5 mg
Number of subjects: 171
Study: 15381950

Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry combined with acid-base equilibrium (ABE) monitoring
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group with only acid-base equilibrium (ABE) monitoring
Number of subjects: 160
Study: 15026090

Group type: EXPERIMENTAL
Intervention: Williams syndrome (WS) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prader-Willi syndrome (PWS) group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adolescents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adults
Number of subjects: 0
Study: 10426833

Group type: EXPERIMENTAL
Intervention: Exercise training (24-week program)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 51
Study: 7554709

Group type: EXPERIMENTAL
Intervention: Mofegiline (single oral doses up to 48 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mofegiline (daily doses for 28 days up to 24 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mofegiline (doses up to 24 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mofegiline (doses up to 48 mg and 24 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mofegiline (48 mg single dose and 24 mg multiple daily dose)
Number of subjects: 0
Study: 2124210

Group type: EXPERIMENTAL
Intervention: 0.8 g pefloxacin, given orally
Number of subjects: 83

Group type: COMPARATOR
Intervention: 1.0 g cefotaxime, given intramuscularly
Number of subjects: 83
Study: 6103255

Group type: EXPERIMENTAL
Intervention: Heparin (1 IU kg‐1 h‐1) administered intravenously for 3‐5 days during and after operation.
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no heparin treatment).
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Heparin administration.
Number of subjects: 95
Study: 31802116

Group type: EXPERIMENTAL
Intervention: Craving for high-fat foods
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Craving for carbohydrates/starches
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Cognitive restraint of eating
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Disinhibition of eating
Number of subjects: 811
Study: 31099859

Group type: EXPERIMENTAL
Intervention: Twice-Daily Radiotherapy (TDRT)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Once-Daily Radiotherapy (ODRT)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Matched cohort ODRT
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Matched cohort TDRT
Number of subjects: 778

Group type: COMPARATOR
Intervention: Overall Survival ODRT
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Overall Survival TDRT
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Progression-Free Survival
Number of subjects: 778
Study: 29433368

Group type: EXPERIMENTAL
Intervention: Briefing session with observations of a properly performed scenario
Number of subjects: 0

Group type: COMPARATOR
Intervention: Briefing session without observations of a properly performed scenario
Number of subjects: 0
Study: 26785745

Group type: EXPERIMENTAL
Intervention: Preemptive kidney transplantation
Number of subjects: 390

Group type: COMPARATOR
Intervention: Dialysis for less than 36 months
Number of subjects: 390
Study: 24065172

Group type: EXPERIMENTAL
Intervention: Varus knee brace
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Valgus knee brace
Number of subjects: 20

Group type: COMPARATOR
Intervention: No brace
Number of subjects: 20
Study: 23029859

Group type: EXPERIMENTAL
Intervention: Increasingly authentic instructional formats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small-group assignment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teacher training
Number of subjects: 0
Study: 20234886

Group type: EXPERIMENTAL
Intervention: Oxidized surface implant
Number of subjects: 35

Group type: COMPARATOR
Intervention: Machined surface implant
Number of subjects: 35
Study: 17050557

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate combination (SFC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 0
Study: 15842028

Group type: EXPERIMENTAL
Intervention: 8-session Short Psychodynamic Supportive Psychotherapy + pharmacotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: 16-session Short Psychodynamic Supportive Psychotherapy + pharmacotherapy
Number of subjects: 0
Study: 12128042

Group type: EXPERIMENTAL
Intervention: 9-week after-school, small group, activities-based intervention
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 208
Study: 10443133

Group type: EXPERIMENTAL
Intervention: Plasma homocysteine concentration in Hungary
Number of subjects: 71

Group type: COMPARATOR
Intervention: Plasma homocysteine concentration in other countries
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Correlation between plasma homocysteine concentration and cardiovascular mortality
Number of subjects: 71
Study: 7797748

Group type: EXPERIMENTAL
Intervention: Exercise echocardiography
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dobutamine echocardiography
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dipyridamole echocardiography
Number of subjects: 100
Study: 30003429

Group type: EXPERIMENTAL
Intervention: Physician-implemented medication screening tool
Number of subjects: 732

Group type: COMPARATOR
Intervention: Usual medical and pharmaceutical care
Number of subjects: 732
Study: 28817295

Group type: EXPERIMENTAL
Intervention: Plans with zero co-pay tiers for generic statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plans without zero co-pay tiers for generic statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plans with zero co-pay tiers for generic OADs
Number of subjects: 0
Study: 26242730

Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg orally every twenty four hours)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 120
Study: 24217313

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (5,000 U weekly for 8 weeks)
Number of subjects: 70